Translational Genomics Research Institute

Analysis

Translational Genomics Research Institute is a registered charity in United States, based in Phoenix, AZ. It received its IRS tax-exemption ruling in December 2002, 24 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending September 2023, Translational Genomics Research Institute reported income of $49.6m and spending of $81.1m, spending 164% of what it took in. Across the 5 years on record, from September 2019 to September 2023, income fell from $77.4m to $49.6m (-36%), an average of -10% a year. The sharpest change came in the year to September 2021, when income rose by 137%. Over the whole period it spent 94% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Translational Genomics Research Institute sits at the 93rd percentile: it is larger than about 93% of them. Against every charity in United States with reported income it ranks in the 99th percentile, and in the 98th percentile within AZ. Charities of a similar size with the same main cause include Vassar Health Connecticut Inc ($49.6m), Southeast Inc ($49.6m) and Montefiore Einstein Advanced Care ($49.6m).

On its Form 990 for the period ending September 2023, revenue came from contributions and grants 81% and program service revenue 23% of the total. Compensation of current officers, directors and key employees was $5.3m (6.5% of expenses). Other salaries and wages came to $33.6m. At year end it held assets of $145.2m against liabilities of $54.7m, net assets of $90.4m. It reported 496 employees.